6533b873fe1ef96bd12d55b6

RESEARCH PRODUCT

false

subject

0301 basic medicineDrugmedicine.medical_specialtyCombination therapySports medicinemedia_common.quotation_subjectPharmacologyCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineIn vivoGene expressionMedicinePhysical and Theoretical ChemistryMolecular BiologySpectroscopymedia_commonbusiness.industryRegeneration (biology)Organic ChemistrySkeletal muscle030229 sport sciencesGeneral MedicineComputer Science Applications030104 developmental biologymedicine.anatomical_structurebusinessIntramuscular injection

description

Skeletal muscle injuries in competitive sports cause lengthy absences of athletes from tournaments. This is of tremendous competitive and economic relevance for both the athletes and their respective clubs. Therapy for structural muscle lesions aims to promote regeneration and fast-track return-to-play. A common clinical treatment strategy for muscle injuries is the intramuscular injection of calf blood compound and the homeopathic drug, Tr14. Although the combination of these two agents was reported to reduce recovery time, the regulatory mechanism whereby this occurs remains unknown. In this in vivo study, we selected a rat model of mechanical muscle injury to investigate the effect of this combination therapy on muscle regeneration. Gene expression analysis and histological images revealed that this combined intramuscular injection for muscle lesions can enhance the expression of pro-myogenic genes and proteins and accelerate muscle regeneration. These findings are novel and depict the positive effects of calf blood compound and the homeopathic drug, Tr14, which are utilized in the field of Sports medicine.